Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction

• Manuscript Highlights. • HFpEF is associated with reduced ATP production in the myocardium. • Ubiquinol and d-ribose both contribute to the generation of myocardial ATP. • Both ubiquinol and d-ribose are being studied as supplemental treatments for patients with HFpEF.

Detalles Bibliográficos
Autores principales: Pierce, Janet D., Shen, Qiuhua, Vacek, James, Rahman, Faith K., Krueger, Kathryn J., Gupta, Bhanu, Hiebert, John B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251495/
https://www.ncbi.nlm.nih.gov/pubmed/32477499
http://dx.doi.org/10.1016/j.amsu.2020.05.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251495/
https://www.ncbi.nlm.nih.gov/pubmed/32477499
http://dx.doi.org/10.1016/j.amsu.2020.05.009

Ejemplares similares